Thomas Goode... retweeted
Oral parity is so important for myeloma patients—imagine your doctor recommends by-mouth treatment, but since there's no federal oral parity law, insurance doesn't cover it the same as IV infusion. Keep the IMF fighting for health equity:mmsm.link/3ynouh7 #kNOwMyeloma
Thomas Goode... retweeted
Great news for patients. Happy to see Carvitki approval jumping to 2L for the treatment of adult patients with RRMM who have received at least one prior line of therapy, including a proteasome inhibitor and an immunomodulatory agent, and are refractory to lenalidomide. #MMSM
Thomas Goode... retweeted
Great news for patients. Happy to see Carvitki approval jumping to 2L for the treatment of adult patients with RRMM who have received at least one prior line of therapy, including a proteasome inhibitor and an immunomodulatory agent, and are refractory to lenalidomide. #MMSM
Thomas Goode... retweeted
The second BCMAxCD3 targeted bispecific antibody, Elrexfio (elranatamab) is now approved by @US_FDA for RRMM patients who have received at least 4 prior lines of therapy. #mmsm @pfizer reuters.com/business/healthc…
Thomas Goode... retweeted
Attention #myeloma patients! The Patient Advocate Foundation Medical Insurance Premium Assistance Co-Pay Relief Fund is open. Don't miss out on support for co-pays, co-insurance, deductibles, and medical insurance premiums. copays.org/funds/multiple-my…
#mmsm
Thank you @GSK for allowing me to be a part of this important initiative of bringing light to diversity in clinical trials!
DYK #multiplemyeloma disproportionately impacts African Americans? To get ahead of this disease, we're working with patient advocates to increase the number of African American participants in clinical trials.
2
9
479
Thomas Goode... retweeted
“Multiple myeloma is 2X more prevalent in the African American community, most of the time when African Americans are diagnosed, they’ve never heard of the disease. That’s not okay, we’ve got to do something about that.” — Valarie Traynham. myeloma.org/IMF-Diversity-Eq…
#IMFMPOWER
Thomas Goode... retweeted
Updated Myeloma Treatment Algorithms presented at @IMFmyeloma @CCO_Education symposium today at #ASH22
1. Newly diagnosed transplant ineligible. Either VRd or DRd is OK. Maintenance varies by risk stratification.
Thomas Goode... retweeted
Newly diagnosed with #multiplemyeloma? You are not alone. We are here to help you from diagnosis to long-term survival. ❤️ myeloma.org/multiple-myeloma…
Thomas Goode... retweeted
We need better immunotherapy treatments for extramedullary #myeloma in R/R pts. Results from this Phase II trial of daratumumab with DCEP with... - goo.gl/scholar/MrzAKX #ScholarAlerts
Thomas Goode... retweeted
When you shop at smile.amazon.com and designate the International Myeloma Foundation as your preferred charity, Amazon donates 0.5% of all purchases you make to the IMF, at no added cost to you. myeloma.org/donation/amazon-…
Thomas Goode... retweeted
❤️ this video of Support Group Leaders telling what they wished others knew about #myeloma.
Filmed at the annual support group leaders summit.
#BloodCancerAwarenessMonth
youtu.be/Ca2cs_GKpRM
Thomas Goode... retweeted
What patients and caregivers want YOU to know about #multiplemyeloma. ❤️
myeloma.org/imf-videos/myelo…
#BloodCancerAwarenessMonth #kNOwMyeloma
Thomas Goode... retweeted
Did you know that while myeloma is most frequently found in people aged 65-74, it is also being diagnosed in individuals who are much younger? @Karyopharm is supporting our goal of #myeloma education and awareness this #BloodCancerAwarenessMonth! Thank you!
#kNOwMyeloma
Thomas Goode... retweeted
Are you new to #myeloma? Trying to understand the language? Here's an updated @IMFmyeloma master glossary of myeloma terms & definitions to help: issuu.com/international-myel…
Thomas Goode... retweeted
Breaking: FDA approves cilta cel for relapsed refractory myeloma. This is great news for myeloma patients. endpts.com/we-are-ready-to-g…
Thomas Goode... retweeted
Good Morning #Myeloma community. It’s almost March and I look forward to seeing your actions! #MYelomaACTION
One week more to go, before the IMF launches Myeloma Action Month. This year, we ask you, What #MYelomaACTION will you take for the myeloma community? Learn more at mam.myeloma.org/
#mmsm


























